PREreview del The Validity Gap in Health AI Evaluation: A Cross-Sectional Analysis of Benchmark Composition

Summary of Findings

This paper provides a rigorous analysis of 18,707 consumer health queries across six public benchmarks, revealing four systematic "blind spots" in health AI evaluation: demographic skews, underrepresentation of chronic disease management, lack of clinical document interpretation, and an absence of behavioral health crisis scenarios. The authors move the field forward by introducing a standardized "Query Profile" reporting framework and providing an open-source toolkit to facilitate transparent, reproducible benchmark evaluation. This is well-crafted research on a topic where advances are highly needed.

General Advice: Add a section or discussion on how to build future benchmarks that actively address the gaps found here rather than just auditing the failures of current ones.

Strengths

• Large-Scale Analysis: The study processes a substantial dataset ($N=18,707$), providing robust evidence for the identified compositional gaps.

• Methodological Rigor: The development of a 16-field taxonomy and the use of multi-model agreement analysis significantly enhance the reliability of the classification.

• Clinical Validation: The use of clinician-judged reasonableness (97% agreement) as a validation criterion ensures that the automated tags are clinically meaningful.

• Reproducibility: The release of open-source tagging tools directly enables researchers to adopt the proposed reporting standards.

Major Issues & Suggested Actions

• Empirical Demonstration of Impact: The paper characterizes the absence of evaluation evidence but does not test how these gaps impact model performance.

Action: Include a targeted experiment comparing a state-of-the-art model’s performance on queries from your identified blind spots (e.g., complex chronic care medication titration) versus standard benchmark-style queries to empirically quantify performance degradation.

• Taxonomy subjectivity: The taxonomy is a pragmatic choice, but the results may change under a more granular or alternative ontology.

  Action: Please add a short sensitivity check showing how key labels or counts would shift if you used a finer-grained taxonomy or a different ontology. Or add more justification regarding the choice made.

• Definition of "Clinical Artifacts": The scope of "raw clinical artifacts" (0.6%) is defined narrowly. The author makes a good point about context for the LLM but then does not expand on it.

Action: Provide a deeper discussion on the challenges of interpreting implicit or summarized clinical data—which is common in consumer queries—as this would add significant value to your findings regarding clinical document interpretation. Maybe a follow up paper on this would be great.

Minor Issues & Suggested Actions

• Clarification of "Generations": The definitions of benchmark "Generations" (1, 2, and 3) are essential to the paper's narrative but are buried in the text.

• Action: Move the formal definitions of benchmark generations to the Methods section to improve flow.

Competing interests

The author declares that they have no competing interests.

Use of Artificial Intelligence (AI)

The author declares that they did not use generative AI to come up with new ideas for their review.